The Lancet Public Health· 2022Q1
Demansın 2019 Küresel Prevalansının Tahmini ve 2050'de Öngörülen Prevalansı: Küresel Hastalık Yükü Çalışması 2019 Analizi İçin
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
- 5.239atıf
- Q1SCImago
- 2022yıl
Kısa özet
Demans vakalarının küresel sayısı, öncelikle nüfus artışı ve yaşlanmanın etkisiyle 2019'daki 57,4 milyondan 2050'ye kadar neredeyse üçe katlanarak 152,8 milyona çıkacağı tahmin ediliyor.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- Küresel demans vakalarının 2019'da 57,4 milyondan 2050'de 152,8 milyona yükselmesi bekleniyor.
- Yaşa göre standardize edilmiş prevalansın küresel olarak istikrarlı kalması beklenirken, bölgesel artışlar büyük ölçüde farklılık gösteriyor.
- Kuzey Afrika, Orta Doğu ve Doğu Sahra Altı Afrika, vakalarda en büyük yüzdesel artışları (%350'nin üzerinde) bekliyor.
- Kadınların, 2050'de 1,67 kadın-erkek oranıyla orantısız bir şekilde etkilenmeye devam etmesi bekleniyor.
- Artan vaka sayılarının temel itici güçleri nüfus artışı ve yaşlanmadır.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
BACKGROUND: Given the projected trends in population ageing and population growth, the number of people with dementia is expected to increase. In addition, strong evidence has emerged supporting the importance of potentially modifiable risk factors for dementia. Characterising the distribution and magnitude of anticipated growth is crucial for public health planning and resource prioritisation. This study aimed to improve on previous forecasts of dementia prevalence by producing country-level estimates and incorporating information on selected risk factors. METHODS: We forecasted the prevalence of dementia attributable to the three dementia risk factors included in the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 (high body-mass index, high fasting plasma glucose, and smoking) from 2019 to 2050, using relative risks and forecasted risk factor prevalence to predict GBD risk-attributable prevalence in 2050 globally and by world region and country. Using linear regression models with education included as an additional predictor, we then forecasted the prevalence of dementia not attributable to GBD risks. To assess the relative contribution of future trends in GBD risk factors, education, population growth, and population ageing, we did a decomposition analysis. FINDINGS: We estimated that the number of people with dementia would increase from 57·4 (95% uncertainty interval 50·4-65·1) million cases globally in 2019 to 152·8 (130·8-175·9) million cases in 2050. Despite large increases in the projected number of people living with dementia, age-standardised both-sex prevalence remained stable between 2019 and 2050 (global percentage change of 0·1% [-7·5 to 10·8]). We estimated that there were more women with dementia than men with dementia globally in 2019 (female-to-male ratio of 1·69 [1·64-1·73]), and we expect this pattern to continue to 2050 (female-to-male ratio of 1·67 [1·52-1·85]). There was geographical heterogeneity in the projected increases across countries and regions, with the smallest percentage changes in the number of projected dementia cases in high-income Asia Pacific (53% [41-67]) and western Europe (74% [58-90]), and the largest in north Africa and the Middle East (367% [329-403]) and eastern sub-Saharan Africa (357% [323-395]). Projected increases in cases could largely be attributed to population growth and population ageing, although their relative importance varied by world region, with population growth contributing most to the increases in sub-Saharan Africa and population ageing contributing most to the increases in east Asia. INTERPRETATION: Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform national planning efforts and decisions. Multifaceted approaches, including scaling up interventions to address modifiable risk factors and investing in research on biological mechanisms, will be key in addressing the expected increases in the number of individuals affected by dementia. FUNDING: Bill & Melinda Gates Foundation and Gates Ventures.
Yazarların özeti; kaynağından alınmıştır. The Lancet Public Health, 2022 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Psikiyatri ve Ruh Sağlığı
Psychiatry and Mental healthMedicine